Health Care & Life Sciences » Pharmaceuticals | Sinovac Biotech Ltd.

Sinovac Biotech Ltd.

Sinovac Biotech Ltd.
Stock Exchange NASDAQ Stock Market
EPS
$0.35
Market Cap
$383.81 M
Shares Outstanding
59.32 M
Public Float
37.94 M

Profile

Address
No. 15 Zhi Tong Road
Beijing Beijing 102200
China
Employees -
Website http://www.sinovacbio.com
Updated 07/08/2019
Sinovac Biotech Ltd. is a holding and biopharmaceutical company, which engages in the research, development, manufacturing, and commercialization of vaccines that protect against human infectious diseases including, without limitation, hepatitis A, hepatitis B, hand foot and mouth disease. It operates through the Mainland China and Hong Kong geographical segments. Its product pipelines include Healive, Bilive, Anflu, PANFLU.

Financials

View All
Created with Highcharts 5.0.14Sinovac Biotech Ltd.Net Income. Fiscal year is January-December. All values USD Thousands.7 4427 4428518516886882 9342 93425 80725 80721 78221 78220132014201520162017201805k10k15k20k25k30k
Created with Highcharts 5.0.14Sinovac Biotech Ltd.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.72 52472 52463 10163 10167 41467 41472 43172 431174 346174 346229 650229 650201320142015201620172018050k100k150k200k250k

Wei Dong Yin
Chairman, President, CEO & Secretary
Guo Wei Wang
Director